GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Apyx Medical Corp (FRA:BOV) » Definitions » Cyclically Adjusted Revenue per Share

Apyx Medical (FRA:BOV) Cyclically Adjusted Revenue per Share : €1.11 (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Apyx Medical Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Apyx Medical's adjusted revenue per share for the three months ended in Dec. 2024 was €0.355. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €1.11 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Apyx Medical's average Cyclically Adjusted Revenue Growth Rate was -2.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -0.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 0.20% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -3.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Apyx Medical was 5.40% per year. The lowest was -7.10% per year. And the median was -0.45% per year.

As of today (2025-05-07), Apyx Medical's current stock price is €0.96. Apyx Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was €1.11. Apyx Medical's Cyclically Adjusted PS Ratio of today is 0.86.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Apyx Medical was 14.58. The lowest was 0.77. And the median was 2.81.


Apyx Medical Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Apyx Medical's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apyx Medical Cyclically Adjusted Revenue per Share Chart

Apyx Medical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.89 1.00 1.02 1.07 1.11

Apyx Medical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.07 1.06 1.12 0.96 1.11

Competitive Comparison of Apyx Medical's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Apyx Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apyx Medical's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Apyx Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Apyx Medical's Cyclically Adjusted PS Ratio falls into.


;
;

Apyx Medical Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Apyx Medical's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.355/133.1571*133.1571
=0.355

Current CPI (Dec. 2024) = 133.1571.

Apyx Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201503 0.277 99.621 0.370
201506 0.265 100.684 0.350
201509 0.258 100.392 0.342
201512 0.238 99.792 0.318
201603 0.258 100.470 0.342
201606 0.306 101.688 0.401
201609 0.331 101.861 0.433
201612 -0.607 101.863 -0.793
201703 0.254 102.862 0.329
201706 0.283 103.349 0.365
201709 0.072 104.136 0.092
201712 0.094 104.011 0.120
201803 0.084 105.290 0.106
201806 0.116 106.317 0.145
201809 0.090 106.507 0.113
201812 0.144 105.998 0.181
201903 0.149 107.251 0.185
201906 0.176 108.070 0.217
201909 0.202 108.329 0.248
201912 0.221 108.420 0.271
202003 0.132 108.902 0.161
202006 0.112 108.767 0.137
202009 0.173 109.815 0.210
202012 0.275 109.897 0.333
202103 0.212 111.754 0.253
202106 0.271 114.631 0.315
202109 0.293 115.734 0.337
202112 0.433 117.630 0.490
202203 0.329 121.301 0.361
202206 0.282 125.017 0.300
202209 0.266 125.227 0.283
202212 0.344 125.222 0.366
202303 0.328 127.348 0.343
202306 0.362 128.729 0.374
202309 0.324 129.860 0.332
202312 0.388 129.419 0.399
202403 0.272 131.776 0.275
202406 0.326 132.554 0.327
202409 0.299 133.029 0.299
202412 0.355 133.157 0.355

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Apyx Medical  (FRA:BOV) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Apyx Medical's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.96/1.11
=0.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Apyx Medical was 14.58. The lowest was 0.77. And the median was 2.81.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Apyx Medical Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Apyx Medical's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Apyx Medical Business Description

Traded in Other Exchanges
Address
5115 Ulmerton Road, Clearwater, FL, USA, 33760
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Apyx Medical Headlines

No Headlines